On the public citation graph
PTEN in Lung Cancer: Dealing with the Problem, Building on New Knowledge and Turning the Game Around
Inferred edges come from two machine sources: sweeps of open repository
metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is
labelled with the one it came from. Neither is a complete citation index — absence here is not
evidence of absence.
1 of the 115 references listed on this page is in the Retraction Watch database as retracted (export 2026-10-21): 10.1007/s13277-015-4150-3 (notice 2021-12-21).
Dataset join, best-effort; this page does not check the publisher record.
Retraction Watch data via Crossref Labs, used with credit; OpenCitations Index (CC0) and Meta (CC BY 4.0);
dataset doi:10.7910/DVN/WT8VOA (CC BY 4.0).
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated
CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/cam4.191openalex-snapshotAlterations of INPP4B, PIK3CA and pAkt of the PI3K pathway are associated with squamous cell carcinoma of the lung
inferredcites →https://doi.org/10.1002/cam4.2220openalex-snapshotMicroRNA‐4286 promotes cell proliferation, migration, and invasion via PTEN regulation of the PI3K/Akt pathway in non‐small cell lung cancer
inferredcites →https://doi.org/10.1002/cbf.3331openalex-snapshotMicroRNA‐130b targets PTEN to induce resistance to cisplatin in lung cancer cells by activating Wnt/β‐catenin pathway
inferredcites →https://doi.org/10.1002/cncr.30794openalex-snapshotNext‐generation sequencing and clinical outcomes of patients with lung adenocarcinoma treated with stereotactic body radiotherapy
inferredcites →https://doi.org/10.1007/s00262-017-2098-4openalex-snapshotCharacterization of PD-L1 expression in Chinese non-small cell lung cancer patients with PTEN expression as a means for tissue quality screening
inferredcites →https://doi.org/10.1007/s11010-012-1443-3openalex-snapshotMicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN
inferredcites →https://doi.org/10.1016/j.jtho.2017.09.1951openalex-snapshotLongitudinal Cell-Free DNA Analysis in Patients with Small Cell Lung Cancer Reveals Dynamic Insights into Treatment Efficacy and Disease Relapse
inferredcites →https://doi.org/10.1016/j.lungcan.2019.01.013openalex-snapshotPTEN inactivation induces epithelial-mesenchymal transition and metastasis by intranuclear translocation of β-catenin and snail/slug in non-small cell lung carcinoma cells
inferredcites →https://doi.org/10.1038/s41388-019-0685-xopenalex-snapshotEffect of PTEN inactivating germline mutations on innate immune cell function and thyroid cancer-induced macrophages in patients with PTEN hamartoma tumor syndrome
inferredcites →https://doi.org/10.1038/srep43013openalex-snapshotPTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer
inferredcites →https://doi.org/10.1073/pnas.0811212106openalex-snapshotA phosphorylation-dependent intramolecular interaction regulates the membrane association and activity of the tumor suppressor PTEN
inferredcites →https://doi.org/10.1074/jbc.m610141200openalex-snapshotMitogen-activated Protein Kinase Kinase-4 Promotes Cell Survival by Decreasing PTEN Expression through an NFκB-dependent Pathway
inferredcites →https://doi.org/10.1093/annonc/mdp060openalex-snapshotEfficacy of everolimus (RAD001) in patients with advanced NSCLC previously treated with chemotherapy alone or with chemotherapy and EGFR inhibitors
inferredcites →https://doi.org/10.1093/hmg/7.3.507openalex-snapshotMutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation
inferredcites →https://doi.org/10.1097/jto.0b013e31824de0d6openalex-snapshotBrief Report: A Phase II “Window-of-Opportunity” Frontline Study of the mTOR Inhibitor, Temsirolimus Given as a Single Agent in Patients with Advanced NSCLC, an NCCTG Study
inferredcites →https://doi.org/10.1158/0008-5472.can-10-0043openalex-snapshotLoss of PTEN Expression by Blocking Nuclear Translocation of EGR1 in Gefitinib-Resistant Lung Cancer Cells Harboring Epidermal Growth Factor Receptor–Activating Mutations
inferredcites →https://doi.org/10.1158/1078-0432.ccr-12-2347openalex-snapshotPhosphoinositide 3-Kinase (PI3K) Pathway Alterations Are Associated with Histologic Subtypes and Are Predictive of Sensitivity to PI3K Inhibitors in Lung Cancer Preclinical Models
inferredcites →https://doi.org/10.1158/1078-0432.ccr-13-1638openalex-snapshotIdentification of a Subset of Human Non–Small Cell Lung Cancer Patients with High PI3Kβ and Low PTEN Expression, More Prevalent in Squamous Cell Carcinoma
inferredcites →https://doi.org/10.1172/jci16147openalex-snapshotRapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells
inferredcites →https://doi.org/10.1172/jci39374openalex-snapshotThe polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells
inferredcites →https://doi.org/10.1177/1010428317709639openalex-snapshotPhosphatase and tensin homolog deleted on chromosome 10 degradation induced by NEDD4 promotes acquired erlotinib resistance in non–small-cell lung cancer
inferredcites →https://doi.org/10.1186/s13058-014-0430-xopenalex-snapshotOvercoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positive breast cancer by co-targeting mammalian target of rapamycin, protein kinase B, or mitogen-activated protein kinase kinase
inferredcites →https://doi.org/10.1186/s40880-019-0354-zopenalex-snapshotIdentification of genetic alterations associated with primary resistance to EGFR‐TKIs in advanced non‐small‐cell lung cancer patients with EGFR sensitive mutations
inferredcites →https://doi.org/10.12659/msm.912581openalex-snapshotUpregulation of Long Noncoding RNA GAS5 Inhibits Lung Cancer Cell Proliferation and Metastasis via miR-205/PTEN Axis
inferredcites →https://doi.org/10.1371/journal.pone.0030427openalex-snapshotSignaling Networks Associated with AKT Activation in Non-Small Cell Lung Cancer (NSCLC): New Insights on the Role of Phosphatydil-Inositol-3 kinase
inferredcites →https://doi.org/10.18632/oncotarget.11068openalex-snapshotPTEN expression is a prognostic marker for patients with non-small cell lung cancer: a systematic review and meta-analysis of the literature
inferredcites →https://doi.org/10.2147/lctt.s161738openalex-snapshotResponse to rapamycin analogs but not PD-1 inhibitors in PTEN-mutated metastatic non-small-cell lung cancer with high tumor mutational burden
inferredcites →https://doi.org/10.4132/jptm.2018.03.12openalex-snapshotMolecular Screening of Small Biopsy Samples Using Next-Generation Sequencing in Korean Patients with Advanced Non-small Cell Lung Cancer: Korean Lung Cancer Consortium (KLCC-13-01)
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4131651openalex-extractedComprehensive Library of Drug Response and Pan-Omic Analysis Identified Therapeutic Candidates and Accompanying Prognostic Biomarkers for Asian Cholangiocarcinoma
inferred← citeshttps://doi.org/10.1002/cam4.4933openalex-snapshotIntegrative metabolomics and transcriptomics analysis reveals novel therapeutic vulnerabilities in lung cancer
inferred← citeshttps://doi.org/10.1002/jcla.23328openalex-snapshotAssociation of phosphatase and tension homologue deleted on chromosome ten polymorphism rs1903858, but not serum levels with the risk of non–small‐cell lung cancer: A case‐control study
inferred← citeshttps://doi.org/10.1007/s00432-021-03828-8openalex-snapshotDrug resistance of targeted therapy for advanced non-small cell lung cancer harbored EGFR mutation: from mechanism analysis to clinical strategy
inferred← citeshttps://doi.org/10.1016/j.isci.2022.105182openalex-snapshotComprehensive drug response profiling and pan-omic analysis identified therapeutic candidates and prognostic biomarkers for Asian cholangiocarcinoma
inferred← citeshttps://doi.org/10.1016/j.modpat.2023.100106openalex-snapshotPTEN Deficiency in Tubo-Ovarian High-Grade Serous Carcinoma is Associated with Poor Progression-Free Survival and is Mutually Exclusive with CCNE1 Amplification
inferred← citeshttps://doi.org/10.1016/j.tranon.2022.101364openalex-snapshotThe PI3K/Akt/mTOR pathway in lung cancer; oncogenic alterations, therapeutic opportunities, challenges, and a glance at the application of nanoparticles
inferred← citeshttps://doi.org/10.1017/s1460396919000876openalex-snapshotA review of predictive, prognostic and diagnostic biomarkers for non-small-cell lung cancer: towards personalised and targeted cancer therapy
inferred← citeshttps://doi.org/10.1021/acsami.4c21740openalex-snapshotCRISPR-dCas9-Mediated PTEN Activation via Tumor Cell Membrane-Coated Nanoplatform Enhances Sensitivity to Tyrosine Kinase Inhibitors in Nonsmall Cell Lung Cancer
inferred← citeshttps://doi.org/10.1021/acsptsci.1c00040openalex-snapshotIdentification of Novel MicroRNAs Targeting SARS-CoV-2 through the Regulation of TMPRSS2/PI3K/AKT/PTEN Alignment in Lung Cancer: An in Silico Analysis
inferred← citeshttps://doi.org/10.1038/s41419-023-05802-3openalex-snapshotThe long non-coding RNA keratin-7 antisense acts as a new tumor suppressor to inhibit tumorigenesis and enhance apoptosis in lung and breast cancers
inferred← citeshttps://doi.org/10.1080/21655979.2021.1872191openalex-snapshotCircular RNA circ_0001287 inhibits the proliferation, metastasis, and radiosensitivity of non-small cell lung cancer cells by sponging microRNA miR-21 and up-regulating phosphatase and tensin homolog expression
inferred← citeshttps://doi.org/10.1109/access.2023.3234294openalex-snapshotEfficient Bioinspired Feature Selection and Machine Learning Based Framework Using Omics Data and Biological Knowledge Data Bases in Cancer Clinical Endpoint Prediction
inferred← citeshttps://doi.org/10.1111/bpa.70143openalex-snapshotPTEN homozygous deletion is a negative prognostic factor in tumor treating fields‐treated glioblastoma, IDH wildtype patients
inferred← citeshttps://doi.org/10.1136/jitc-2025-012288openalex-snapshotGenetic drivers of tumor microenvironment and immunotherapy resistance in non-small cell lung cancer: the role of KEAP1 , SMARCA4 , and PTEN mutations
inferred← citeshttps://doi.org/10.1155/2022/3472745openalex-snapshotβ-Elemene Restrains PTEN mRNA Degradation to Restrain the Growth of Lung Cancer Cells via METTL3-Mediated N6 Methyladenosine Modification
inferred← citeshttps://doi.org/10.1200/po.22.00040openalex-snapshotDurable Response to Combined Osimertinib and Pralsetinib Treatment for Osimertinib Resistance Due to Novel IntergenicANK3-RETFusion inEGFR-Mutated Non–Small-Cell Lung Cancer
inferred← citeshttps://doi.org/10.2147/ijn.s505539openalex-snapshotUtilizing Nanoparticles to Overcome Anti-PD-1/PD-L1 Immunotherapy Resistance in Non-Small Cell Lung cancer: A Potential Strategy
inferred← citeshttps://doi.org/10.2174/1566523220666200523165159openalex-snapshotIntegrated Analysis of mRNA-seq and miRNA-seq to Identify c-MYC, YAP1 and miR-3960 as Major Players in the Anticancer Effects of Caffeic Acid Phenethyl Ester in Human Small Cell Lung Cancer Cell Line
inferred← citeshttps://doi.org/10.3389/fonc.2021.663183openalex-snapshotTargeting c-Jun in A549 Cancer Cells Exhibits Antiangiogenic Activity In Vitro and In Vivo Through Exosome/miRNA-494-3p/PTEN Signal Pathway
inferred← citeshttps://doi.org/10.3389/jpps.2026.16610openalex-snapshotThe cross-talk between GSK-3β, RKIP, and PTEN as potential targets for therapeutic implications in cancer: a comprehensive insight
inferred← citeshttps://doi.org/10.3390/cancers12051125openalex-snapshotPrecision Medicine for NSCLC in the Era of Immunotherapy: New Biomarkers to Select the Most Suitable Treatment or the Most Suitable Patient
inferred← citeshttps://doi.org/10.3390/cancers14041041openalex-snapshotReal-World Time on Treatment with First-Line Pembrolizumab Monotherapy for Advanced NSCLC with PD-L1 Expression ≥ 50%: 3-Year Follow-Up Data
inferred← citeshttps://doi.org/10.3390/ijms232214083openalex-snapshotBPR0C261, An Analogous of Microtubule Disrupting Agent D-24851 Enhances the Radiosensitivity of Human Non-Small Cell Lung Cancer Cells via p53-Dependent and p53-Independent Pathways
inferred← citeshttps://doi.org/10.3390/ijms25147817openalex-snapshotPTEN Depletion Increases Radiosensitivity in Response to Ataxia Telangiectasia-Related-3 (ATR) Inhibition in Non-Small Cell Lung Cancer (NSCLC)
inferred← citeshttps://doi.org/10.3390/jpm11020154openalex-snapshotComprehensive Profiling of Genomic and Transcriptomic Differences between Risk Groups of Lung Adenocarcinoma and Lung Squamous Cell Carcinoma
inferred← citeshttps://doi.org/10.3390/medsci14020254openalex-snapshotLoss of PTEN as an Independent Poor Prognosis Indicator in Lung Adenocarcinoma, but Not in Squamous Cell Carcinoma, Is Associated with an Immunosuppressive Tumor Microenvironment and Distinct Co-Mutational Profiles
inferred← citeshttps://doi.org/10.5603/ep.104958openalex-snapshotLong non-coding RNA MIR22HG impedes the progression of anaplastic thyroid carcinoma via targeting miR-141-3p/PTEN/AKT axis
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID:
icsacinstitute.org/submit.